Miriam Merad is awarded the Sjöberg Prize, worth USD one million, for her discovery of new targets for cancer therapies in the immune system.

The post She is the winner of the Sjöberg Prize 2025 appeared first on NLS.

Dignitana has received a Notice of Allowance from the Korean Intellectual Property Office for a patent titled “Scalp Cooling Apparatus, Method and System.”

The post Dignitana expands IP with new patent in Korea appeared first on NLS.

With the new national cancer strategy, Minister Vestre vows to make Norway world-leading in cancer. Here are Oslo Cancer Cluster's reactions.

The post Norway: New national cancer strategy presented appeared first on NLS.

AlzeCure Pharma's project NeuroRestore ACD856 has received EUR 2.5 million from the EU's European Innovation Council.

The post AlzeCure receives EU grant for Phase 2 clinical trial appeared first on NLS.

The Finnish biotech company developing stem cell therapies for vision restoration, has raised funding from Voima Ventures, Finnish family offices (Stephen Industries Inc. & Biothom Oy), private investors, and Business Finland.

The post StemSight secures EUR 2.3 million in funding appeared first on NLS.

The decision is in line with Aqilion's strategy to focus the business to the internal pipeline programs within chronic inflammation.

The post Aqilion divests its holding in Oncorena Holding appeared first on NLS.

The Gates Foundation, Novo Nordisk Foundation, and Wellcome have announced the launch of the Gram-Negative Antibiotic Discovery Innovator (Gr-ADI), a USD 50 million investment that will focus on combatting antimicrobial resistance (AMR) caused by a specific range of bacteria that are among the leading contributors to AMR-associated deaths.

The post Philanthropic partnership launches new initiative to tackle AMR appeared first on NLS.

The FDA has granted Fast Track Designation to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA).

The post Lundbeck’s potential treatment for MSA receives Fast Track Designation appeared first on NLS.

Abera Bioscience reports that its first in vivo study with a novel nasal influenza vaccine candidate has delivered promising results in the mouse model.

The post Abera announces promising results appeared first on NLS.

All participants are determined to establish Europe as a global leader in Artificial Intelligence (AI), advancing AI development and application.

The post 60+ European companies launch the ‘EU AI Champions Initiative’ appeared first on NLS.